StartupsFinSMEs5 days ago
Goldenrod Therapeutics Holds Initial Close of $6.5M Seed Funding
1 min read
Goldenrod Therapeutics held an initial close of $6.5 million in seed funding. The round supports the company's development of treatments for inflammatory diseases. The funding will advance the firm's pipeline toward clinical trials.
Level
Hype check
Tap to vote and see what everyone thinks.
